E. Compérat

525 total citations
31 papers, 347 citations indexed

About

E. Compérat is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Rheumatology. According to data from OpenAlex, E. Compérat has authored 31 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Rheumatology. Recurrent topics in E. Compérat's work include Bladder and Urothelial Cancer Treatments (16 papers), Urinary and Genital Oncology Studies (9 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). E. Compérat is often cited by papers focused on Bladder and Urothelial Cancer Treatments (16 papers), Urinary and Genital Oncology Studies (9 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). E. Compérat collaborates with scholars based in France, Netherlands and Austria. E. Compérat's co-authors include Emmanuel Chartier‐Kastler, F. Capron, André Reitz, P. Denys, A Delcourt, Colette Adida, Josée Audouin, J Diébold, A. Le Tourneau and Thierry Jo Molina and has published in prestigious journals such as Journal of Clinical Oncology, Urologic Oncology Seminars and Original Investigations and International Journal of Surgical Pathology.

In The Last Decade

E. Compérat

29 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Compérat France 7 137 104 96 91 75 31 347
Nye Thane Ngo Singapore 10 22 0.2× 88 0.8× 88 0.9× 93 1.0× 16 0.2× 30 264
Anthony Pham United States 11 56 0.4× 69 0.7× 200 2.1× 88 1.0× 17 0.2× 30 344
B Court France 12 115 0.8× 152 1.5× 179 1.9× 305 3.4× 12 0.2× 29 453
Giuseppe Di Fino Italy 13 80 0.6× 69 0.7× 159 1.7× 148 1.6× 25 0.3× 26 374
Shigeyoshi Kamata Japan 9 31 0.2× 59 0.6× 96 1.0× 75 0.8× 9 0.1× 29 224
Voûte Pa Netherlands 13 25 0.2× 69 0.7× 294 3.1× 162 1.8× 17 0.2× 39 498
R. Bastús Spain 9 13 0.1× 138 1.3× 133 1.4× 397 4.4× 18 0.2× 22 462
M. Guschmann Germany 9 25 0.2× 15 0.1× 73 0.8× 46 0.5× 48 0.6× 29 350
Mitsuhiro Tambo Japan 12 50 0.4× 73 0.7× 194 2.0× 131 1.4× 5 0.1× 45 409
Michael J. Allen Canada 11 31 0.2× 39 0.4× 64 0.7× 140 1.5× 7 0.1× 36 282

Countries citing papers authored by E. Compérat

Since Specialization
Citations

This map shows the geographic impact of E. Compérat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Compérat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Compérat more than expected).

Fields of papers citing papers by E. Compérat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Compérat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Compérat. The network helps show where E. Compérat may publish in the future.

Co-authorship network of co-authors of E. Compérat

This figure shows the co-authorship network connecting the top 25 collaborators of E. Compérat. A scholar is included among the top collaborators of E. Compérat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Compérat. E. Compérat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rollin, Pierre E., Évanguelos Xylinas, E. Compérat, et al.. (2022). Instauration du traitement adjuvant endovésical par épirubicine des tumeurs de vessie n’infiltrant pas le muscle : premier retour national d’expérience du CC-AFU vessie. Progrès en Urologie. 32(5). 326–331. 2 indexed citations
3.
Neuzillet, Y., G. Pignot, E. Compérat, et al.. (2018). Recommandations françaises du Comité de Cancérologie de l’AFU – Actualisation 2018–2020 : tumeurs de la vessie. Progrès en Urologie. 28(S1). R48–R80. 28 indexed citations
4.
Cohen, J., M.O. Timsit, Olivier Zerbib, et al.. (2017). Le cancer du rein sporadique du sujet jeune : étude des particularités cliniques et anatomopathologiques d’une cohorte bicentrique. Progrès en Urologie. 28(2). 94–106. 2 indexed citations
5.
Rouprêt, Morgan, Pierre Colin, E. Compérat, et al.. (2016). Recommandations en onco-urologie 2016-2018 du CCAFU : Tumeurs de la voie excrétrice supérieure. Progrès en Urologie. 27. S55–S66. 3 indexed citations
7.
Peyronnet, B., Susanna Cattarino, Thomas Seisen, et al.. (2015). Influence of pathological factors on oncological outcomes after robot-assisted radical prostatectomy for localized prostate cancer: Results of a prospective study. Urologic Oncology Seminars and Original Investigations. 33(7). 330.e1–330.e7. 17 indexed citations
8.
Bruins, H.M., Virginia Hernández, Erik Veskimäe, et al.. (2014). 118 Does the extent of lymphadenectomy impact survival after radical cystectomy: A systematic review. European Urology Supplements. 13(1). e118–e118b. 2 indexed citations
11.
Compérat, E., Morgan Rouprêt, Philippe Camparo, Pierre Conort, & Catherine Mazerolles. (2011). Diagnostic anatomopathologique et prise en charge clinique des lésions planes urothéliales détectées à l’aide de l’acide aminolevulinique (Hexvix®). Progrès en Urologie. 21(3). 157–165. 4 indexed citations
12.
Renard‐Penna, Raphaële, Morgan Rouprêt, E. Compérat, et al.. (2011). Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: Results from a prospective study. Urologic Oncology Seminars and Original Investigations. 31(4). 448–454. 37 indexed citations
13.
Audouin, Marie, Aurélie Revaux, Vincent Misraï, et al.. (2009). Tumeur urothéliale primitive du haut appareil urinaire et seconde localisation ultérieure intravésicale. Progrès en Urologie. 19(9). 583–588. 8 indexed citations
14.
Peycelon, Matthieu, Christophe Vaessen, Vincent Misraï, et al.. (2008). Résultats de la néphrectomie partielle pour les carcinomes à cellules rénales de plus de 4 cm. Progrès en Urologie. 19(2). 69–74. 5 indexed citations
15.
Bart, S., et al.. (2008). Tumeur épithéliale primitive de la tête de l’épididyme. Progrès en Urologie. 19(1). 66–68.
16.
Rouprêt, Morgan, Géraldine Cancel‐Tassin, E. Compérat, et al.. (2008). PHENOL SULFOTRANSFERASE SULT1A1*2 ALLELE AND ENHANCED RISK OF UPPER URINARY TRACT UROTHELIAL CELL CARCINOMA. European Urology Supplements. 7(3). 291–291. 1 indexed citations
17.
Simon, Paul, et al.. (2008). Une fistule rectovésicale révélatrice d’une maladie de Crohn. Progrès en Urologie. 18(3). 193–195.
18.
Chargari, Cyrus, E. Compérat, Sylvestre Le Moulec, et al.. (2008). BENEFITS OF VIRTUAL MICROSCOPY ON PROSTATIC BIOPSY CORES EXAMINATION. European Urology Supplements. 7(3). 285–285. 1 indexed citations
19.
Ruffion, A., E. Compérat, Morgan Rouprêt, & Emmanuel Chartier‐Kastler. (2007). Chapitre C - Cancer de vessie et vessie neurologique. Progrès en Urologie. 17(3). 431–435. 5 indexed citations
20.
Chartier-Kästler, E., E. Compérat, & A. Ruffion. (2007). Chapitre F - Trouble de compliance vésicale et vessie neurologique. Progrès en Urologie. 17(3). 442–447. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026